Memantine hydrochloride(CAS: 41100-52-1)

Memantine hydrochloride (CAS: 41100-52-1) is a medication used to treat moderate to severe Alzheimer's disease. It is a derivative of memantine, an NMDA receptor antagonist, with the chemical formula C10H17N3O·HCl. It appears as a white crystalline powder, is soluble in water, and has a molecular weight of approximately 229.7 g/mol. Its primary role is to regulate glutamate activity in the brain, which helps slow the progression of Alzheimer's symptoms.

Memantine hydrochloride (CAS: 41100-52-1) is primarily used as a treatment for moderate to severe Alzheimer's disease. It is also employed in research to study NMDA receptor function and may be used in veterinary medicine for similar neurological conditions. Its applications are focused on managing cognitive decline and as a pharmaceutical compound in clinical trials for neurodegenerative disorders.

Memantine hydrochloride (CAS: 41100-52-1) is generally safe when used as prescribed, with common side effects including dizziness, confusion, and headache. It is approved by the FDA for Alzheimer's treatment and follows strict safety guidelines. Proper handling, such as avoiding skin and eye contact, and storage in a secure location are essential to ensure safety during use and handling.

Memantine hydrochloride (CAS: 41100-52-1) should be stored in a cool, dry place, away from direct light, in a tightly sealed container. It is stable at temperatures between 20-25°C and should be protected from moisture. Proper storage conditions are critical to maintaining its efficacy and preventing degradation over time.